We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$2.35B
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 17.11% |
| 3 | Miscellaneous | 15.83% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
1801
Farmland Partners
FPI
$472M
| $761K | ﹤0.01% |
62,362
-266,915
| -81% | -$2.99M |
|
1802
Churchill Downs
CHDN
$5.98B
| $753K | ﹤0.01% |
+5,412
| New | +$741K |
|
1803
MetLife
MET
$60.7B
| $752K | ﹤0.01% |
13,299
-6,907
| -34% | -$383K |
|
1804
Universal Insurance Holdings
UVE
$1.22B
| $747K | ﹤0.01% |
48,409
-146,655
| -75% | -$2.43M |
|
1805
Sonoco
SON
$4.93B
| $744K | ﹤0.01% |
+12,610
| New | +$759K |
|
1806
Prothena Corp
PRTA
$490M
| $742K | ﹤0.01% |
+10,869
| New | +$701K |
|
|
PL.WS
1807
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
| $741K | ﹤0.01% |
230,080
-19,920
| -8% | -$13.1K |
|
1808
Manchester United
MANU
$3.57B
| $739K | ﹤0.01% |
30,300
-136,447
| -82% | -$2.82M |
|
|
CLINW
1809
CALL
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
| $738K | ﹤0.01% |
70,431
| – | – |
|
1810
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$258M
| $736K | ﹤0.01% |
+13,322
| New | +$691K |
|
1811
Cooper-Standard Automotive
CPS
$462M
| $734K | ﹤0.01% |
51,500
-68,308
| -57% | -$832K |
|
1812
Getty Images
GETY
$107M
| $734K | ﹤0.01% |
150,324
+47,176
| +46% | +$270K |
|
|
TIXT
1813
DELISTED
TELUS International
TIXT
| $732K | ﹤0.01% |
48,219
-96,801
| -67% | -$1.69M |
|
1814
NNN REIT
NNN
$8.53B
| $727K | ﹤0.01% |
+17,000
| New | +$732K |
|
1815
Apollo Global Management
APO
$77.8B
| $727K | ﹤0.01% |
+9,464
| New | +$633K |
|
|
LSXMK
1816
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $726K | ﹤0.01% |
28,649
-834,878
| -97% | -$18.7M |
|
1817
Purple Innovation
PRPL
$16.6M
| $726K | ﹤0.01% |
10,445
+6,679
| +177% | +$481K |
|
1818
Roper Technologies
ROP
$39.1B
| $721K | ﹤0.01% |
+1,500
| New | +$679K |
|
|
FAASW
1819
CALL
DELISTED
DigiAsia Corp Warrant
FAASW
| $721K | ﹤0.01% |
66,420
| – | – |
|
1820
Berkshire Hathaway Class B
BRK.B
$1.08T
| $719K | ﹤0.01% |
2,109
-50,698
| -96% | -$16.5M |
|
1821
Red Robin
RRGB
$159M
| $717K | ﹤0.01% |
51,813
-66,650
| -56% | -$894K |
|
1822
Encompass Health
EHC
$11.9B
| $714K | ﹤0.01% |
10,549
-196,004
| -95% | -$12.3M |
|
|
INZY
1823
DELISTED
Inozyme Pharma
INZY
| $712K | ﹤0.01% |
127,907
-67,190
| -34% | -$397K |
|
1824
Design Therapeutics
DSGN
$953M
| $711K | ﹤0.01% |
112,922
-67,997
| -38% | -$416K |
|
1825
PJT Partners
PJT
$4.66B
| $711K | ﹤0.01% |
10,212
-2,910
| -22% | -$201K |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $2.35B of net new capital in Q2 2023, opening 648 new positions and adding to 710 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Gilead Sciences, an estimated $402M trimmed.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.